These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33921719)

  • 1. Podophyllotoxin: History, Recent Advances and Future Prospects.
    Shah Z; Gohar UF; Jamshed I; Mushtaq A; Mukhtar H; Zia-Ui-Haq M; Toma SI; Manea R; Moga M; Popovici B
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic and application perspectives of azapodophyllotoxins: alternative scaffolds of podophyllotoxin.
    Kumar A; Kumar V; Alegria AE; Malhotra SV
    Curr Med Chem; 2011; 18(25):3853-70. PubMed ID: 21824101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments towards podophyllotoxin congeners as potential apoptosis inducers.
    Kamal A; Hussaini SM; Malik MS
    Anticancer Agents Med Chem; 2015; 15(5):565-74. PubMed ID: 25469512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
    Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
    Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy.
    Zhao W; Cong Y; Li HM; Li S; Shen Y; Qi Q; Zhang Y; Li YZ; Tang YJ
    Nat Prod Rep; 2021 Mar; 38(3):470-488. PubMed ID: 32895676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances in the Chemistry and Biology of Podophyllotoxins.
    Yu X; Che Z; Xu H
    Chemistry; 2017 Apr; 23(19):4467-4526. PubMed ID: 27726183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxypodophyllotoxin: a promising therapeutic agent from herbal medicine.
    Khaled M; Jiang ZZ; Zhang LY
    J Ethnopharmacol; 2013 Aug; 149(1):24-34. PubMed ID: 23792585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in semisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: an update (2008-2010).
    Lv M; Xu H
    Mini Rev Med Chem; 2011 Sep; 11(10):901-9. PubMed ID: 21781026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of podophyllotoxins.
    Imbert TF
    Biochimie; 1998 Mar; 80(3):207-22. PubMed ID: 9615861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII.
    Yang L; Liu YQ; Tan H; Li WG; Tian X
    Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007.
    Xu H; Lv M; Tian X
    Curr Med Chem; 2009; 16(3):327-49. PubMed ID: 19149581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemistry and Biological Activities of Naturally Occurring and Structurally Modified Podophyllotoxins.
    Jin L; Song Z; Cai F; Ruan L; Jiang R
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents.
    Liu J; Cao B; Gao Y; Bai M; Mei X; Chen H; Jiang YG; Huang DJ
    J Asian Nat Prod Res; 2013 Sep; 15(9):985-92. PubMed ID: 23859462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4'-Demethyl-deoxypodophyllotoxin glucoside isolated from Podophyllum hexandrum exhibits potential anticancer activities by altering Chk-2 signaling pathway in MCF-7 breast cancer cells.
    Zilla MK; Nayak D; Amin H; Nalli Y; Rah B; Chakraborty S; Kitchlu S; Goswami A; Ali A
    Chem Biol Interact; 2014 Dec; 224():100-7. PubMed ID: 25446499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antineoplastic Agents. 585. Isolation of Bridelia ferruginea Anticancer Podophyllotoxins and Synthesis of 4-Aza-podophyllotoxin Structural Modifications.
    Pettit GR; Searcy JD; Tan R; Cragg GM; Melody N; Knight JC; Chapuis JC
    J Nat Prod; 2016 Mar; 79(3):507-18. PubMed ID: 26938998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A multivariate analysis approach to antineoplastic and antiviral structure-activity relationships to a series of podophyllotoxins].
    Doré JC; Viel C; Pageot N; Gordaliza M; Castro A; del Corral JM; Feliciano AS
    J Pharm Belg; 1996; 51(1):9-18. PubMed ID: 8882445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podophyllotoxin derivatives: a patent review (2012 - 2014).
    Kamal A; Ali Hussaini SM; Rahim A; Riyaz S
    Expert Opin Ther Pat; 2015; 25(9):1025-34. PubMed ID: 26027947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podophyllotoxins: current status and recent developments.
    Damayanthi Y; Lown JW
    Curr Med Chem; 1998 Jun; 5(3):205-52. PubMed ID: 9562603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucoside Derivatives Of Podophyllotoxin: Synthesis, Physicochemical Properties, And Cytotoxicity.
    Zi CT; Yang L; Kong QH; Li HM; Yang XZ; Ding ZT; Jiang ZH; Hu JM; Zhou J
    Drug Des Devel Ther; 2019; 13():3683-3692. PubMed ID: 31695335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Application of Podophyllotoxin Derivatives to Fight Against Multidrug-Resistant Cancer Cells.
    Guo Q; Jiang E
    Curr Top Med Chem; 2021; 21(19):1712-1724. PubMed ID: 33441065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.